Back to 
Bank of America Corp.
Bank of America Corp.
NPCE
15 quarters
Position history for Bank of America Corp.'s holdings in Neuropace, Inc.
Yes. Bank of America holds 20,249 shares of NPCE (Neuropace), worth $321,757, as of its Q2 2026 13F filing. It reduced the position by 4,449 shares (-18.0%) from Q1 2026. Bank of America has held NPCE in every 13F on record since Q4 2022, 15 quarterly filings.
Current Value
$321,757
Current Shares
20,249
Total Value Change
+$302,363
Total Shares Change
+7,233
Quarter-by-Quarter History
Other major holders of NPCE: Polar Capital Holdings Plc, Morgan Stanley, BlackRock, Inc.